Bronte Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.74K Hold
16,905
﹤0.01% 54
2025
Q4
$37.2K Buy
+16,905
New +$27.2K ﹤0.01% 35

Other funds holding GUTS

Bronte Capital Management's GUTS Position: Q1 2026 in Review

Bronte Capital Management held its Fractyl Health (GUTS) position steady in Q1 2026 at 16,905 shares worth $7.74K. The position accounts for ﹤0.01% of the portfolio, ranked #54.

Bronte Capital Management first reported a position in GUTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $37.2K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Bronte Capital Management held 16,905 shares of Fractyl Health worth $7.74K as of Q1 2026.
  • Bronte Capital Management left its Fractyl Health share count unchanged in Q1 2026.
  • Fractyl Health made up ﹤0.01% of Bronte Capital Management's portfolio in Q1 2026, its #54 holding.
  • Bronte Capital Management first reported a position in Fractyl Health in Q4 2025 and has held it in 2 quarters since.
  • Bronte Capital Management's Fractyl Health position peaked at $37.2K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Bronte Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.